Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME)

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Radiotherapy (RT) is increasingly recognized for its immunomodulatory effects beyond direct tumor cell killing.
• The interplay between RT, the tumor immune microenvironment (TIME), and immunotherapy is a rapidly evolving field.
• Hypofractionation, delivering higher doses per fraction, is a recent RT advancement with potential differential impacts on immune responses.

Purpose of the Study:

• To review the impact of conventional and hypofractionation RT schedules on the TIME.
• To elucidate how RT's immunomodulatory effects vary with dose and fractionation.
• To provide insights for rationally combining RT with immunotherapy and targeted therapies.

Main Methods:

• Literature review of studies investigating RT effects on the TIME.
• Analysis of immunological responses to different RT dose and fractionation regimens.
• Synthesis of findings to inform combination treatment strategies.

Main Results:

• RT significantly influences immune cell populations and function within the TIME.
• Fractionation schedules, particularly hypofractionation, can differentially modulate the TIME.
• Specific RT parameters may enhance or suppress anti-tumor immunity.

Conclusions:

• Understanding RT's immunomodulatory effects is essential for successful combination therapies.
• Tailoring RT regimens to specific TIME characteristics may optimize immunotherapy efficacy.
• Further research is needed to guide the selection of optimal RT-immunotherapy combinations.